Partnering with visionary startups to drive innovation, scale solutions, and transform the pharmaceutical and nutraceutical industries.
Investing in Potential, Delivering Possibilities
Strategic Investments for Lasting Impact
Colorcon Ventures invests in innovative solutions within the pharmaceutical and nutraceutical industries, with a focus on technologies that improve patient compliance, and support the authentication of dosage forms to combat counterfeiting.
We are particularly interested in transformational technologies that disrupt traditional dosage delivery methods, as well as smart solutions for digital and personalized medicine. Our portfolio also includes breakthrough manufacturing innovations and intelligent systems that address unmet needs across pharmaceutical technologies and supply chains. In addition to funding, we provide strategic support through commercial consultation, along with guidance on sales and scientific development to help our portfolio companies grow.
(Please note that we do not invest in active pharmaceutical ingredients (API) or therapeutic molecule development.)
Where We Invest
Focused primarily on early and mid-stage investments
Seeking startups with product-market fit and revenue growth
Aligned with Colorcon’s expertise in pharma and nutra innovation
How We Invest
$50M fund dedicated to pharma and nutra advancements
Initial investments of $0.5-2.5M
Reserved capital for follow-on funding
Co-investing with top-tier VC firms
Our Growing Profile
-
Offering a platform technology for oral therapies that target specific tissues, leading to better outcomes through increased bioavailability and higher efficacy for unmet conditions.
-
Through developing advanced Artificial Intelligence and Machine Learning solutions, Atomwise helps pharmaceutical industry overcome the challenges of drug discovery and create better medicines faster.
-
Replacing the Syringe with a Pill, i2O Therapeutics has developed a disruptive ionic liquid technology that enables oral delivery of biologics and other injection-based drugs. The ability to deliver injectable therapies orally has the potential to significantly improve patient adherence and outcomes.
-
Leading provider of personalized 3D printed chewable nutritional gummies with a clean ingredient profile, Remedy leverages its patented 3D-printing technology to produce gummy vitamin stacks that are enjoyable and convenient to take as a single oral dose.
-
Through its bio-simulation platform, VeriSIM Life enables the pharmaceutical industry to narrow down most efficacious compounds, de-risk R&D decisions, predict preclinical outcomes prior to human trials, reduce animal testing and therefore facilitating speed to market at a lower cost.
-
From small and large molecules to cell and gene therapy, solid oral dosages to injectables and beyond, Apprentice leverages artificial intelligence and augmented reality to get medicine to patients faster.
-
Innovative clinical nutrition company, operating at the intersection of Nutra, Pharma and Digital wellness, providing value-based care and a data driven solution, focusing on patient engagement and adherence.
-
Leading developer of a new class of therapeutics to modulate human microbiome based on rational design of defined consortia of bacteria that are essential for gut health.
-
Exited
The Team
Bringing together expertise to drive innovation and growth.
Industry-leading expertise in pharmaceutical excipients, coating systems, and modified release technologies. Our team brings decades of experience in transforming pharmaceutical development and manufacturing.
A trusted partner in corporate venture capital, Cerity Partners brings a wealth of experience in helping companies scale through strategic investments and operational support. Together, we maximize value for startups in the pharma space.
Let’s Shape the Future Together
We’re looking for innovative startups ready to scale. Let’s work together to accelerate growth and create lasting impact.
